• Tardyferon

  Form: tablets, prolonged release

  Active substance	Dosage
  ferrous sulfate	80 mg

  ATC code: B03AA07

  Manufacturer: Pierre Fabre Iberica, S.A.

• Tardyferon

  Form: tablets, prolonged release

  Active substance	Dosage
  ferrous sulfate	80 mg

  ATC code: B03AA07

  Manufacturer: Pierre Fabre Medicament

• Tardyferon fol

  Form: tablets, prolonged release

  Active substance	Dosage
  Ferrous sulfate	80 mg
  Folic acid	0.35 mg

  ATC code: B03AD03

  Manufacturer: Pierre Fabre Medicament

• Tardyferon-fol

  Form: tablets, prolonged release

  Active substance	Dosage
  Ferrous sulfate	80 mg
  Folic acid	0.35 mg

  ATC code: B03AD

  Manufacturer: Pierre Fabre Farmaka A.E.

• Tardyferon-fol

  Form: tablets, modified release

  Active substance	Dosage
  Ferrous sulfate	80 mg
  Folic acid	0.35 mg

  ATC code: B03AD03

  Manufacturer: Pierre Fabre Medicament

• Tardyferon-fol

  Form: tablets, prolonged release

  Active substance	Dosage
  Ferrous sulfate	80 mg
  Folic acid	0.35 mg

  ATC code: B03AD03

  Manufacturer: Pierre Fabre Médicament

• Tardyferon-fol

  Form: tablets, prolonged release

  Active substance	Dosage
  Ferrous sulfate	80 mg
  Folic acid	0.35 mg

  ATC code: B03AD03

  Manufacturer: Pierre Fabre Médicament Portugal, Ltd.

• Tardyferon-fol

  Form: tablets, prolonged release

  Active substance	Dosage
  Ferrous sulfate	80 mg
  Folic acid	0.35 mg

  ATC code: B03AD03

  Manufacturer: Pierre Fabre Medicament

• Tardyferon-fol

  Form: tablets, film-coated, prolonged release

  Active substance	Dosage
  Ferrous sulfate	80 mg
  Folic acid	0.35 mg

  ATC code: B03AD03

  Manufacturer: Pierre Fabre Farmaka A.E.

• Tardyferon-fol

  Form: tablets, prolonged release

  Active substance	Dosage
  Ferrous sulfate	80 mg
  Folic acid	0.35 mg

  ATC code: B03AD03

  Manufacturer: Pierre Fabre Médicament Portugal, Ltd.

• Tardyferon-fol

  Form: tablets, prolonged release

  Active substance	Dosage
  Ferrous sulfate	80 mg
  Folic acid	0.35 mg

  ATC code: B03AD03

  Manufacturer: Pierre Fabre Médicament Portugal, Ltd.

• Tardyferon-fol

  Form: tablets, prolonged release

  Active substance	Dosage
  Ferrous sulfate	80 mg
  Folic acid	0.35 mg

  ATC code: B03AA07

  Manufacturer: Pierre Fabre Farmaka A.E.

• Tardyferon-fol

  Form: tablets, modified release

  ATC code: B03AD03

  Manufacturer: Pierre Fabre Medicament

• Tardyferon-fol

  Form: tablets, modified release

  Active substance	Dosage
  Ferrous sulfate	80 mg
  Folic acid	0.35 mg

  ATC code: B03AD03

  Manufacturer: Pierre Fabre Medicament

• Tardysol

  Form: solution, oral

  Active substance	Dosage
  iron	20 mg/ml

  ATC code: B03AA07

  Manufacturer: Pierre Fabre Medicament Production

• Tardysol baby

  Form: solution, oral

  Active substance	Dosage
  iron	20 mg/ml

  ATC code: B03AA07

  Manufacturer: Pierre Fabre Medicament Production

• Tarfazolin

  Form: powder for preparation of solution for injection and infusion

  Active substance	Dosage
  Cefazolin sodium	1 g

  ATC code: J01DB04

  Manufacturer: Tarchomin Pharmaceutical Works 'Polfa' S.A.

• Targin

  Form: tablets, prolonged release

  Active substance	Dosage
  oxycodone hydrochloride	10 mg
  naloxone hydrochloride	5.00 mg

  ATC code: N02AA55

  Manufacturer: Fidelio Healthcare Limburg GmbH Mundipharma DC B.V.

• Targin

  Form: tablets, prolonged release

  Active substance	Dosage
  oxycodone hydrochloride	5 mg
  naloxone hydrochloride	2.50 mg

  ATC code: N02AA55

  Manufacturer: Fidelio Healthcare Limburg GmbH Mundipharma DC B.V.

• Targin

  Form: tablets, prolonged release

  Active substance	Dosage
  oxycodone hydrochloride	40 mg
  naloxone hydrochloride	20.00 mg

  ATC code: N02AA55

  Manufacturer: Fidelio Healthcare Limburg GmbH Mundipharma DC B.V.

• Targin

  Form: tablets, prolonged release

  Active substance	Dosage
  Oxycodone hydrochloride	20 mg
  Naloxone hydrochloride	10.00 mg

  ATC code: N02AA55

  Manufacturer: Fidelio Healthcare Limburg GmbH Mundipharma DC B.V.

• Targocid

  Form: powder and solvent for preparation of solution for injection infusion or oral solution

  Active substance	Dosage
  Teicoplanin	400 mg

  ATC code: J01XA02

  Manufacturer: sanofi-aventis, s.r.o.

• Targocid

  Form: powder and solvent for preparation of solution for injection infusion or oral solution

  Active substance	Dosage
  Teicoplanin	200 mg

  ATC code: J01XA02

  Manufacturer: sanofi-aventis, s.r.o.

• Targocid

  Form: powder and solvent for preparation of solution for injection infusion or oral solution

  Active substance	Dosage
  Teicoplanin	200 mg

  ATC code: J01XA02

  Manufacturer: Vianex S.A.

• Targocid

  Form: powder and solvent for preparation of solution for injection infusion or oral solution

  Active substance	Dosage
  Teicoplanin	400 mg

  ATC code: J01XA02

  Manufacturer: Sanofi Romania Ltd.

• Tarivid 200

  Form: tablets, film-coated

  Active substance	Dosage
  ofloxacin	200 mg

  ATC code: J01MA01

  Manufacturer: Opella Healthcare International SAS

• Taromentin

  Form: powder for preparation of solution for injection and infusion

  Active substance	Dosage
  amoxicillin	1000 mg
  clavulanic acid	200 mg

  ATC code: J01CR02

  Manufacturer: Tarchomin Pharmaceutical Works 'Polfa' S.A.

• Taromentin

  Form: tablets, film-coated

  Active substance	Dosage
  amoxicillin	875 mg
  clavulanic acid	125 mg

  ATC code: J01CR02

  Manufacturer: Tarchomin Pharmaceutical Works 'Polfa' S.A.

• Taromentin

  Form: tablets, film-coated

  Active substance	Dosage
  amoxicillin	500 mg
  clavulanic acid	125 mg

  ATC code: J01CR02

  Manufacturer: Tarchomin Pharmaceutical Works 'Polfa' S.A.

• Taromentin

  Form: powder for preparation of solution for injection and infusion

  Active substance	Dosage
  Amoxicillin	500 mg
  clavulanic acid	100 mg

  ATC code: J01CR02

  Manufacturer: Tarchomin Pharmaceutical Works 'Polfa' S.A.

• Taromentin

  Form: powder for preparation of oral suspension

  Active substance	Dosage
  amoxicillin	400 mg/5 ml
  clavulanic acid	57 mg/5 ml

  ATC code: J01CR02

  Manufacturer: Tarchomin Pharmaceutical Works 'Polfa' S.A.

• Taromentin

  Form: solution for infusion, powder for preparation of

  Active substance	Dosage
  Sodium amoxicillin	2000 mg
  clavulanic acid	No input provided

  ATC code: J01CR02

  Manufacturer: Tarchomin Pharmaceutical Works 'Polfa' S.A.

• Tarsime

  Form: powder for preparation of injection suspension or injection solution

  Active substance	Dosage
  cefuroxime	750 mg

  ATC code: J01DC02

  Manufacturer: Tarchomin Pharmaceutical Works 'Polfa' S.A.

• Tarsime

  Form: powder for preparation of solution for injection and infusion

  Active substance	Dosage
  cefuroxime	1500 mg

  ATC code: J01DC02

  Manufacturer: Tarchomin Pharmaceutical Works 'Polfa' S.A.

• Tarsime

  Form: tablets, film-coated

  Active substance	Dosage
  cefuroxime axetil	150.36 mg

  ATC code: J01DC02

  Manufacturer: Tarchomin Pharmaceutical Works 'Polfa' S.A.

• Tarsime

  Form: tablets, film-coated

  Active substance	Dosage
  Cefuroxime axetil	300.72 mg

  ATC code: J01DC02

  Manufacturer: PenCef Pharma GmbH Tarchomin Pharmaceutical Works "Polfa" S.A.

• Tarsime

  Form: tablets, film-coated

  Active substance	Dosage
  Cefuroxime axetil	601.44 mg

  ATC code: J01DC02

  Manufacturer: PenCef Pharma GmbH Tarchomin Pharmaceutical Works "Polfa" S.A.

• Tartriaxon

  Form: powder for preparation of solution for injection and infusion

  Active substance	Dosage
  Ceftriaxone sodium	2.23 g
  Ceftriaxone	2.08 g

  ATC code: J01DD04

  Manufacturer: Tarchomin Pharmaceutical Works 'Polfa' S.A.

• Tartriaxon

  Form: powder for preparation of solution for injection and infusion

  Active substance	Dosage
  Ceftriaxone	1 g

  ATC code: J01DD04

  Manufacturer: Tarchomin Pharmaceutical Works 'Polfa' S.A.

• Tavanic

  Form: solution for infusion

  Active substance	Dosage
  levofloxacin	5.1246 mg

  ATC code: J01MA12

  Manufacturer: Sanofi-Aventis Deutschland GmbH

• Tazocin

  Form: solution for infusion, powder for preparation of

  Active substance	Dosage
  sodium piperacillin	2 g
  sodium tazobactam	0.25 g

  ATC code: J01CR05

  Manufacturer: Wyeth Lederle S.r.l

• Tazocin

  Form: solution for infusion, powder for preparation of

  Active substance	Dosage
  sodium piperacillin	4 g
  sodium tazobactam	0.5 g

  ATC code: J01CR05

  Manufacturer: Wyeth Lederle S.r.l

• Tdap vaccine

  Form: solution for injection in ampoule-syringe

  Active substance	Dosage
  diphtheria toxoid	Not less than 2 IU
  tetanus toxoid	Not less than 20 IU
  pertussis toxoid	20 mcg

  ATC code: J07AJ52

  Manufacturer: AJ Vaccines A/S

• Tears naturale ii

  Form: drops, ophthalmic solution

  Active substance	Dosage
  Hypromellose	3 mg
  Dextran	1 mg

  ATC code: S01XA20

  Manufacturer: Alcon Laboratories Belgium

• Teenia

  Form: tablets, film-coated

  Active substance	Dosage
  Drospirenone	3 mg
  Ethinylestradiol	0.02 mg

  ATC code: G03AA12

  Manufacturer: Gedeon Richter Plc.

• Teenia

  Form: tablets, film-coated

  Active substance	Dosage
  Drospirenone	3 mg
  Ethinylestradiol	0.02 mg

  ATC code: G03AA12

  Manufacturer: Gedeon Richter Plc.

• Tegretol

  Form: suspension, oral

  Active substance	Dosage
  carbamazepine	20 mg

  ATC code: N03AF01

  Manufacturer: Novartis Farmaceutica S.A.

• Tegretol cr 200

  Form: tablets, modified release

  Active substance	Dosage
  carbamazepine	200 mg

  ATC code: N03AF01

  Manufacturer: Novartis Farma S.p.A. Novartis Farmaceutica S.A.

• Tegretol cr 400

  Form: tablets, modified release

  Active substance	Dosage
  carbamazepine	400 mg

  ATC code: N03AF01

  Manufacturer: Novartis Farma S.p.A. Novartis Farmaceutica S.A.

• Teicopix

  Form: powder and solvent for preparation of solution for injection infusion or oral solution

  Active substance	Dosage
  Teicoplanin	400 mg

  ATC code: J01XA02

  Manufacturer: Lek Pharmaceuticals d.d. Salutas Pharma GmbH